Literature DB >> 34103732

Landmark Alzheimer's drug approval confounds research community.

Asher Mullard.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Drug discovery

Year:  2021        PMID: 34103732     DOI: 10.1038/d41586-021-01546-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  32 in total

Review 1.  Can we learn lessons from the FDA's approval of aducanumab?

Authors:  Kathy Y Liu; Robert Howard
Journal:  Nat Rev Neurol       Date:  2021-09-17       Impact factor: 42.937

2.  Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78-94.

Authors:  Malgorzata M Michalowska; Karl Herholz; Rainer Hinz; Chinenye Amadi; Lynn McInnes; Jose M Anton-Rodriguez; Thomas K Karikari; Kaj Blennow; Henrik Zetterberg; Nicholas J Ashton; Neil Pendleton; Stephen F Carter
Journal:  Mol Psychiatry       Date:  2022-07-20       Impact factor: 13.437

3.  Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.

Authors:  Daniela Lecca; Yoo Jin Jung; Michael T Scerba; Inho Hwang; Yu Kyung Kim; Sun Kim; Sydney Modrow; David Tweedie; Shih-Chang Hsueh; Dong Liu; Weiming Luo; Elliot Glotfelty; Yazhou Li; Jia-Yi Wang; Yu Luo; Barry J Hoffer; Dong Seok Kim; Ross A McDevitt; Nigel H Greig
Journal:  Alzheimers Dement       Date:  2022-03-02       Impact factor: 16.655

4.  One-Carbon Insertion and Polarity Inversion Enabled a Pyrrole Strategy to the Total Syntheses of Pyridine-Containing Lycopodium Alkaloids: Complanadine A and Lycodine.

Authors:  Donghui Ma; Brandon S Martin; Katelyn S Gallagher; Takeru Saito; Mingji Dai
Journal:  J Am Chem Soc       Date:  2021-09-27       Impact factor: 16.383

5.  Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease.

Authors:  Zhen Lan; Yanting Chen; Jiali Jin; Yun Xu; Xiaolei Zhu
Journal:  Front Mol Neurosci       Date:  2022-01-14       Impact factor: 5.639

Review 6.  Traditional East Asian Herbal Medicine Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  JiEun Lee; Seungwon Kwon; Chul Jin; Seung-Yeon Cho; Seong-Uk Park; Woo-Sang Jung; Sang-Kwan Moon; Jung-Mi Park; Chang-Nam Ko; Ki-Ho Cho
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

Review 7.  Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.

Authors:  Yara Al Ojaimi; Timothée Blin; Juliette Lamamy; Matthieu Gracia; Aubin Pitiot; Caroline Denevault-Sabourin; Nicolas Joubert; Jean-Pierre Pouget; Valérie Gouilleux-Gruart; Nathalie Heuzé-Vourc'h; Débora Lanznaster; Sophie Poty; Thomas Sécher
Journal:  Pharmacol Ther       Date:  2021-10-20       Impact factor: 13.400

8.  Aducanumab for Alzheimer's disease?

Authors:  Sebastian Walsh; Richard Merrick; Richard Milne; Carol Brayne
Journal:  BMJ       Date:  2021-07-05

Review 9.  Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.

Authors:  Bing Bai; David Vanderwall; Yuxin Li; Xusheng Wang; Suresh Poudel; Hong Wang; Kaushik Kumar Dey; Ping-Chung Chen; Ka Yang; Junmin Peng
Journal:  Mol Neurodegener       Date:  2021-08-12       Impact factor: 14.195

Review 10.  Alzheimer's Disease: Current Perspectives and Advances in Physiological Modeling.

Authors:  E Josephine Boder; Ipsita A Banerjee
Journal:  Bioengineering (Basel)       Date:  2021-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.